Jacob Hoj

Jacob Hoj

Duke University

H-index: 8

North America-United States

About Jacob Hoj

Jacob Hoj, With an exceptional h-index of 8 and a recent h-index of 7 (since 2020), a distinguished researcher at Duke University, specializes in the field of Functional Genomics, CRISPR, Cancer Biology, Metastasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung Adenocarcinoma

CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer

ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1

Identification of novel regulators of response to PI3Ka inhibition in PIK3CA mutant gastric cancer

Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

MCB-613 exploits a collateral sensitivity in drug resistant EGFR-mutant non-small cell lung cancer through covalent inhibition of KEAP1

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Jacob Hoj Information

University

Position

___

Citations(all)

253

Citations(since 2020)

235

Cited By

71

hIndex(all)

8

hIndex(since 2020)

7

i10Index(all)

6

i10Index(since 2020)

5

Email

University Profile Page

Google Scholar

Jacob Hoj Skills & Research Interests

Functional Genomics

CRISPR

Cancer Biology

Metastasis

Top articles of Jacob Hoj

Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung Adenocarcinoma

Cancer Research Communications

2023/11/24

CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer

Molecular Cancer Research

2023/11/1

ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1

Proceedings of the National Academy of Sciences

2023/4/18

Identification of novel regulators of response to PI3Ka inhibition in PIK3CA mutant gastric cancer

Cancer Research

2023/4/4

Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

Nature Communications

2023/3/14

MCB-613 exploits a collateral sensitivity in drug resistant EGFR-mutant non-small cell lung cancer through covalent inhibition of KEAP1

bioRxiv

2023/1/19

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination

Neuro-Oncology Advances

2023/1/1

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Nature cancer

2022/7

ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells

Cell reports

2021/10/26

BSCI-05. ABL2-HSF1-E2F signaling axis promotes lung adenocarcinoma brain metastasis

Neuro-oncology Advances

2021/8

Jacob Hoj
Jacob Hoj

H-Index: 5

The ABL2 kinase regulates an HSF1-dependent transcriptional program required for lung adenocarcinoma brain metastasis

Proceedings of the National Academy of Sciences

2020/12/29

Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells

PLoS One

2020/10/29

Jacob Hoj
Jacob Hoj

H-Index: 5

Clay Rouse
Clay Rouse

H-Index: 8

Abstract B25: An actionable AXL-ABL2-TAZ signaling axis promotes lung adenocarcinoma metastasis to the brain

Molecular Cancer Research

2020/8/1

The Characterization of Tyrosine Kinase-Dependent Signaling Networks Required for Lung Cancer Brain Metastasis

2020

See List of Professors in Jacob Hoj University(Duke University)